AR060926A1 - Solucion anestesica transparente de propofol, con baja irritacion venosa. - Google Patents
Solucion anestesica transparente de propofol, con baja irritacion venosa.Info
- Publication number
- AR060926A1 AR060926A1 ARP070102080A ARP070102080A AR060926A1 AR 060926 A1 AR060926 A1 AR 060926A1 AR P070102080 A ARP070102080 A AR P070102080A AR P070102080 A ARP070102080 A AR P070102080A AR 060926 A1 AR060926 A1 AR 060926A1
- Authority
- AR
- Argentina
- Prior art keywords
- propofol
- anesthetic solution
- venous irritation
- low venous
- transparent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Solucion anestésica transparente de propofol, con baja irritacion venosa, compuesta por lo menos por un 90% al 55% de Propofol, disuelto en un 10% al 45% de un Macrogol 15 hidroestearato (Solutol), teniendo preferiblemente cada 10,815 mg/ml de Propofol, 25% de un Macrogol 15 hidroestearato (Solutol), y eventualmente 0,0515 mg/ml de EDTA.
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP070102080A AR060926A1 (es) | 2007-05-14 | 2007-05-14 | Solucion anestesica transparente de propofol, con baja irritacion venosa. |
| AT08750919T ATE489938T1 (de) | 2007-05-14 | 2008-05-13 | Transparente propofol-narkoselösung mit geringer venenreizung |
| EP08750919A EP2186509B1 (en) | 2007-05-14 | 2008-05-13 | Propofol transparent anaesthetic solution with low venous irritation |
| DE602008003845T DE602008003845D1 (de) | 2007-05-14 | 2008-05-13 | Transparente propofol-narkoselösung mit geringer venenreizung |
| ES08750919T ES2358864T3 (es) | 2007-05-14 | 2008-05-13 | Solución anestésica transparente de profol, con baja irritación venosa. |
| CA2706264A CA2706264C (en) | 2007-05-14 | 2008-05-13 | Propofol transparent anesthetic solution, with low venous irritation threshold |
| PCT/IB2008/001178 WO2008139313A2 (es) | 2007-05-14 | 2008-05-13 | Propofol transparent anesthehic solution with a low i.v. irration threshold |
| US12/600,384 US20100160456A1 (en) | 2007-05-14 | 2008-05-13 | Propofol Solution for Anesthetic Use |
| MX2009012439A MX2009012439A (es) | 2007-05-14 | 2008-05-13 | Solucion anestesica transparente de profol, con baja irritacion venosa. |
| CO09142710A CO6140039A2 (es) | 2007-05-14 | 2009-12-14 | Solucion anestesica transparente de propofol con baja irrigacion venosa |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP070102080A AR060926A1 (es) | 2007-05-14 | 2007-05-14 | Solucion anestesica transparente de propofol, con baja irritacion venosa. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR060926A1 true AR060926A1 (es) | 2008-07-23 |
Family
ID=39681073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102080A AR060926A1 (es) | 2007-05-14 | 2007-05-14 | Solucion anestesica transparente de propofol, con baja irritacion venosa. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100160456A1 (es) |
| EP (1) | EP2186509B1 (es) |
| AR (1) | AR060926A1 (es) |
| AT (1) | ATE489938T1 (es) |
| CA (1) | CA2706264C (es) |
| CO (1) | CO6140039A2 (es) |
| DE (1) | DE602008003845D1 (es) |
| ES (1) | ES2358864T3 (es) |
| MX (1) | MX2009012439A (es) |
| WO (1) | WO2008139313A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2416004B1 (es) * | 2012-01-24 | 2014-01-28 | Investigaciones Farmaceuticas Y Veterinarias, S.L. | Composición farmacéutica que comprende cloruro de isometamidium en solución para el tratamiento de la tripanosomiasis en animales. |
| CN103768055B (zh) * | 2012-10-26 | 2015-11-25 | 上海医药工业研究院 | 注射用依托咪酯组合物及其制备方法 |
| PL3316860T3 (pl) | 2015-07-01 | 2024-10-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Układy dostarczania propofolu |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1202719B1 (en) * | 1999-06-21 | 2006-05-31 | Kuhnil Pharmaceutical Co., Ltd. | Anesthetic composition for intravenous injection comprising propofol |
| KR100482269B1 (ko) * | 2002-10-08 | 2005-04-14 | 센츄론(주) | 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법 |
| US7326735B2 (en) * | 2003-04-30 | 2008-02-05 | Parnell Laboratories (Aust) Pty Limited | Formulations for anaesthetic use |
| US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
| EP1713444A4 (en) * | 2004-02-13 | 2012-06-20 | Bioavailability Inc | MICROEMULSION PREPARATION OF HIGHLY CONCENTRATED PROPOFOL FOR APPLICATIONS IN ANESTHESIA |
| JP5068750B2 (ja) * | 2005-07-08 | 2012-11-07 | フィジカ ファルマ | プロポフオールを含む透明な薬学的水性マイクロエマルジョン及び製造方法 |
-
2007
- 2007-05-14 AR ARP070102080A patent/AR060926A1/es unknown
-
2008
- 2008-05-13 ES ES08750919T patent/ES2358864T3/es active Active
- 2008-05-13 AT AT08750919T patent/ATE489938T1/de not_active IP Right Cessation
- 2008-05-13 EP EP08750919A patent/EP2186509B1/en not_active Not-in-force
- 2008-05-13 CA CA2706264A patent/CA2706264C/en not_active Expired - Fee Related
- 2008-05-13 WO PCT/IB2008/001178 patent/WO2008139313A2/es not_active Ceased
- 2008-05-13 US US12/600,384 patent/US20100160456A1/en not_active Abandoned
- 2008-05-13 MX MX2009012439A patent/MX2009012439A/es active IP Right Grant
- 2008-05-13 DE DE602008003845T patent/DE602008003845D1/de active Active
-
2009
- 2009-12-14 CO CO09142710A patent/CO6140039A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2186509A2 (en) | 2010-05-19 |
| MX2009012439A (es) | 2010-03-11 |
| CO6140039A2 (es) | 2010-03-19 |
| EP2186509B1 (en) | 2010-12-01 |
| ES2358864T3 (es) | 2011-05-16 |
| WO2008139313A8 (es) | 2010-03-18 |
| ATE489938T1 (de) | 2010-12-15 |
| CA2706264C (en) | 2012-07-17 |
| WO2008139313A3 (es) | 2009-04-02 |
| CA2706264A1 (en) | 2008-11-20 |
| US20100160456A1 (en) | 2010-06-24 |
| WO2008139313A2 (es) | 2008-11-20 |
| DE602008003845D1 (de) | 2011-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR056816A1 (es) | Composicion con ácido docosapentenoico | |
| GT201200020A (es) | Composición de insulina de acción prolongada | |
| UY31543A1 (es) | Sistema de administracion de rnai de interferencia y usos del mismo | |
| ECSP066794A (es) | Nuevos compuestos como inhibidores de serina proteasa ns3 del virus de la hepatitis c | |
| DOP2006000008A (es) | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 | |
| EA202091999A2 (ru) | Применение ингибиторов dpp iv | |
| CR9114A (es) | 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion | |
| CL2012000215A1 (es) | Composicion farmaceutica que comprende un fucano en combinacion con por lo menos un excipiente, relleno, portador o diluyente; kit que la comprende; y uso para inhibir, prevenir o tratar una enfermedad proliferativa o inflamatoria tal como una adhesion fibrosa, peritonitis, isquemia y rosacea, entre otras. | |
| BRPI0516577A (pt) | agentes terapêuticos com toxicidade diminuìda | |
| SV2008003018A (es) | Formulaciones medicamentosas que contienen fluoroquinolonas | |
| AR060926A1 (es) | Solucion anestesica transparente de propofol, con baja irritacion venosa. | |
| AR051765A1 (es) | Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas | |
| BRPI0506888A (pt) | composições de suplemento lìquido compreendendo um ou mais medicamentos | |
| CU23632A1 (es) | Métodos para la identificación de candidatos terapéuticos contra enfermedades causadas por flavivirus y moléculas antivirales. | |
| PA8657901A1 (es) | Composicion que comprende una epotilona y metodos para producir dicha composicion | |
| UY29371A1 (es) | Pirroles sustituídos, composiciones que los contienen, proceso de fabricación y utilización | |
| UY30368A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzazepinas, su preparacion, composiciones que las contienen y utilizacion | |
| GT200500264A (es) | Compuestos de quinolina | |
| ECSP088899A (es) | Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparación, composiciones que las contienen y utilización | |
| ECSP088897A (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización | |
| BRPI0702401E2 (pt) | cartão de sinalização | |
| TR200703131A2 (tr) | N-asetilsistein dozaj formu | |
| Hahm | A study on the effects of cultural aspects of UCC with a specialities | |
| GT200500165A (es) | Metabolitos de indolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
| TR200703130A2 (tr) | N-asetilsistein ve c vitamini içeren kombine dozaj formu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |